Verona Pharma (VRNA) Insider Trading & Ownership $53.82 -0.85 (-1.55%) As of 09:35 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Verona Pharma (NASDAQ:VRNA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.80%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$188,928.00Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$9.82 M Get VRNA Insider Trade Alerts Want to know when executives and insiders are buying or selling Verona Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address VRNA Insider Buying and Selling by Quarter Verona Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/6/2024David ZaccardelliCEOSell162,800$5.01$815,628.00 12/6/2024Mark W HahnCFOSell183,728$5.01$920,477.28 12/4/2024David ZaccardelliCEOSell67,608$5.00$338,040.00 12/4/2024Mark W HahnCFOSell58,184$5.00$290,920.00 12/2/2024David ZaccardelliCEOSell3,200$5.00$16,000.00 12/2/2024Mark W HahnCFOSell1,600$5.00$8,000.00 11/29/2024David ZaccardelliCEOSell98,888$5.01$495,428.88 11/29/2024Mark W HahnCFOSell98,704$5.01$494,507.04 11/27/2024David ZaccardelliCEOSell23,240$5.00$116,200.00 11/27/2024Mark W HahnCFOSell12,936$5.00$64,680.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 11/25/2024Kathleen A RickardInsiderSell240,000$4.90$1,176,000.00 11/25/2024Mark W HahnCFOSell1,600$5.00$8,000.00 11/11/2024David ZaccardelliCEOSell2,400$5.00$12,000.00 11/6/2024David R EbsworthDirectorBuy39,360$4.80$188,928.00 11/4/2024David ZaccardelliCEOSell94,144$4.39$413,292.16 11/4/2024Mark W HahnCFOSell80,784$4.39$354,641.76 11/1/2024David ZaccardelliCEOSell46,888$4.38$205,369.44 11/1/2024Mark W HahnCFOSell48,888$4.38$214,129.44 10/25/2024David ZaccardelliCEOSell4,800$4.38$21,024.00 10/24/2024Mark W HahnCFOSell141,360$4.38$619,156.80 10/23/2024David ZaccardelliCEOSell16$4.38$70.08 10/21/2024David ZaccardelliCEOSell110,456$4.38$483,797.28 10/21/2024Mark W HahnCFOSell116,696$4.38$511,128.48 10/18/2024David ZaccardelliCEOSell245,784$4.38$1,076,533.92 10/18/2024Mark W HahnCFOSell249,728$4.38$1,093,808.64 5/3/2024Kathleen A RickardInsiderSell36,248$1.96$71,046.08 (Data available from 1/1/2013 forward) VRNA Insider Trading Activity - Frequently Asked Questions Who is on Verona Pharma's Insider Roster? The list of insiders at Verona Pharma includes Claire Poll, David R Ebsworth, David Zaccardelli, Kathleen A Rickard, Lisa Deschamps, Mark W Hahn, Martin Edwards, and Orbimed Advisors Llc. Learn more on insiders at VRNA. What percentage of Verona Pharma stock is owned by insiders? 4.80% of Verona Pharma stock is owned by insiders. Learn more on VRNA's insider holdings. Which Verona Pharma insiders have been buying company stock? The following insiders have purchased VRNA shares in the last 24 months: David R Ebsworth ($505,728.00), and Martin Edwards ($62,074.24). How much insider buying is happening at Verona Pharma? Insiders have purchased a total of 233,096 VRNA shares in the last 24 months for a total of $567,802.24 bought. Which Verona Pharma insiders have been selling company stock? The following insiders have sold VRNA shares in the last 24 months: Claire Poll ($706,998.48), David Zaccardelli ($6,864,137.20), Kathleen A Rickard ($2,051,968.72), Mark W Hahn ($7,394,222.56), and Orbimed Advisors Llc ($9,003,837.04). How much insider selling is happening at Verona Pharma? Insiders have sold a total of 5,383,017 Verona Pharma shares in the last 24 months for a total of $26,021,164.00 sold. Verona Pharma Key ExecutivesDr. David S. Zaccardelli Pharm.D. (Age 60)President, CEO & Executive Director Compensation: $1.27MMr. Mark W. Hahn (Age 61)Chief Financial Officer Compensation: $858.29k11 recent tradesDr. Kathleen A. Rickard M.D. (Age 66)Chief Medical Officer Compensation: $650.83k1 recent tradesMr. Andrew Fisher (Age 54)General Counsel Ms. Victoria StewartDirector of CommunicationsMr. Matthew CasbonVP of Sales, Marketing & TrainingMs. Ostra JewellSenior Vice President of Human ResourcesDr. Tara Rheault M.P.H. (Age 48)Ph.D., Chief Development Officer Mr. Christopher MartinChief Commercial OfficerMs. Caroline DiazSenior Vice President of Regulatory Affairs More Insider Trading Tools from MarketBeat Related Companies SMMT Insider Selling GMAB Insider Selling VTRS Insider Selling ITCI Insider Selling MRNA Insider Selling CTLT Insider Selling SRPT Insider Selling PCVX Insider Selling ROIV Insider Selling BPMC Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Small-Cap Stocks Insiders and Institutions Are Buying3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys This page (NASDAQ:VRNA) was last updated on 1/24/2025 by MarketBeat.com Staff From Our PartnersVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | SponsoredJUST RELEASED: HUGE NEW A.I. TRADEI’ve traded every major tech boom since the dawn of the personal computer. And I can tell you one thing wit...The Oxford Club | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verona Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Verona Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
